12:00 AM
 | 
Jun 10, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Cipla, Meda sales and marketing update

Cipla and Meda added full rights in Latin and South America, the Middle East, Africa and Asia to 2008 and 2009 deals granting Meda exclusive rights to develop and commercialize Cipla's Dymista azelastine/fluticasone in North...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >